Claritev Corp

CTEV

Market cap $910M

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation Announces Third Quarter 2025 Earnings Call.

MCLEAN, Va. & DUBAI, United Arab Emirates--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, and iO Health-FZE, an innovator in AI-driven healthcare technology, today announced a strategic agreement aimed at delivering Optima AI across the Middle East and North Africa (MENA). Through this agreement, Claritev has secured exclusive rights to license,.

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced it has renewed its sponsorship agreement with professional golfer Neal Shipley and signed new sponsorship agreements with Bud Cauley, Ryan Fox and Darren Clarke. These endorsements reflect Claritev's commitment to supporting athletes who exemplify resilience, determinatio.

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, is proud to announce it has been Certified™ by Great Place To Work® for the fourth consecutive year. The prestigious award is based entirely on what current employees say about their experience working at Claritev. This year, 76% of employees said it's a great place to work – 19 points h.

Claritev Corporation (NYSE:CTEV ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 4:05 PM EDT Company Participants Travis Dalton - CEO, President & Chairman Doug Garis - Executive VP & CFO Conference Call Participants Dan Bray - Morgan Stanley Presentation Dan Bray Managing Director Good afternoon, everyone. I'm Dan Bray, Managing Director in the Morgan Stanley Healthcare Group.

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced that members of its management team will participate in person at the following conferences in September 2025: 2025 Wells Fargo Healthcare Conference – Wednesday, September 3, 2025, at the Encore Boston Harbor, Boston, MA (including a presentation at approximately 8:45 am.

Claritev (NYSE:CTEV), a healthcare data analytics and cost management company, reported its second quarter 2025 earnings on August 6, 2025. The standout news is revenue rising to $241.6 million (GAAP) in Q2 2025, which exceeded analyst estimates by $10.2 million (GAAP).

Claritev Corporation (CTEV) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of a loss of $2.69 per share. This compares to a loss of $1.2 per share a year ago.

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation Reports Second Quarter 2025 Results.

CTEV, DOW and BLNK have been added to the Zacks Rank #5 (Strong Sell) List on July 23, 2025.